Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PaTS-COVID trial for prevention and treatment of COVID-19 severe pneumonia in The Gambia
PACTR202101544570971Phase 3Not yet recruiting
- Sponsor
- Medical Research Council Unit The Gambia at LSHTM
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ivermectin and aspirin in coronavirus disease 2019 (COVID-19), sponsored by Medical Research Council Unit The Gambia at LSHTM. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
ivermectinaspirin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202101544570971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202101544570971.